Market Size of Italy Continuous Glucose Monitoring Devices Industry
Study Period | 2018-2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 346 Million |
Market Size (2029) | USD 539.41 Million |
CAGR (2024 - 2029) | 9.29 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Italy Continuous Glucose Monitoring Devices Market Analysis
The Italy Continuous Glucose Monitoring Devices Market size is estimated at USD 346 million in 2024, and is expected to reach USD 539.41 million by 2029, growing at a CAGR of 9.29% during the forecast period (2024-2029).
Within the first year since its inception, the COVID-19 pandemic was responsible for premature deaths, particularly among older individuals. Italy was the first country in Europe affected by COVID-19. Italy was among the countries with the highest mortality. Most people who died of COVID-19 were affected by the co-occurrence of two or more chronic conditions in the same individual. Several studies underlined that diabetes was associated with adverse outcomes in COVID-19 patients. The pandemic boosted opportunities for continuing and expanding innovations in the delivery of diabetes care through virtual consultations between healthcare providers and people with diabetes and the use of diabetes technology.
Continuous glucose monitoring devices estimate blood glucose levels throughout the day and night. These devices help determine blood glucose levels at any time, how blood glucose level changes over a few hours or days, and spot trends. Monitoring blood glucose levels in real-time can help the patient or caregivers make more informed decisions about food, physical activities, and medicines. Keeping blood glucose levels in the target range can help prevent other health problems caused by diabetes, including stroke, kidney disease, nerve damage, hearing loss, hypertension, eye complications, foot complications, skin complications, etc.
Continuous Glucose monitoring is an important tool for insulin-treated people with diabetes, measuring interstitial glucose levels and providing information about glucose trends and rate of change. Various studies demonstrate that people with diabetes, both type 1 and type 2, using CGM systems experience fewer hyperglycemic and hypoglycemic episodes and a significant decrease in glycated hemoglobin (HbA1C) levels. Italian guidelines highlight the importance of selecting and educating patients and caregivers about the use of CGM. The guidelines identify poor glucose control and hypoglycemia as the main indications for CGM use, especially in case of problematic hypoglycemia.
Therefore, owing to the aforementioned factors, the studied market is anticipated to witness growth over the analysis period.
Italy Continuous Glucose Monitoring Devices Industry Segmentation
Continuous glucose monitoring devices are used to diagnose both hyperglycemic and hypoglycemic conditions in diabetic patients throughout the day. The Italian continuous glucose monitoring device market is segmented into components (sensors and durables).
The report offers the value (in USD) and volume (in units) for the above segments.
Component | |
Sensors | |
Durables |
Italy Continuous Glucose Monitoring Devices Market Size Summary
The Italy Continuous Glucose Monitoring (CGM) Devices Market is poised for significant growth over the forecast period, driven by the increasing prevalence of diabetes and advancements in diabetes care technology. The market is characterized by the adoption of CGM devices, which provide real-time blood glucose monitoring, enabling better management of diabetes and prevention of related health complications. The COVID-19 pandemic has further accelerated the adoption of these devices by highlighting the importance of managing chronic conditions like diabetes. The Italian healthcare system, with its decentralized structure and patient-centered National Diabetes Plan, plays a crucial role in facilitating access to CGM devices, ensuring that individuals with diabetes receive the necessary care and support without financial burden.
Technological innovations in CGM devices, particularly in sensor technology, are expected to drive market expansion. The sensors segment currently holds a significant share, with advancements such as nanoparticle sensors promising improved glucose tracking. The market is consolidated, with key players like Abbott, Medtronic, and Dexcom leading the way through continuous innovation and strategic growth initiatives. Regulatory frameworks and reimbursement policies in Italy further support the market's growth by providing a structured approach to diabetes care and ensuring that patients have access to the latest technologies. As the market evolves, the integration of CGM devices into primary health services and the focus on improving diabetes care quality are anticipated to contribute to the market's robust growth trajectory.
Italy Continuous Glucose Monitoring Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Component
-
2.1.1 Sensors
-
2.1.2 Durables
-
-
Italy Continuous Glucose Monitoring Devices Market Size FAQs
How big is the Italy Continuous Glucose Monitoring Devices Market?
The Italy Continuous Glucose Monitoring Devices Market size is expected to reach USD 346 million in 2024 and grow at a CAGR of 9.29% to reach USD 539.41 million by 2029.
What is the current Italy Continuous Glucose Monitoring Devices Market size?
In 2024, the Italy Continuous Glucose Monitoring Devices Market size is expected to reach USD 346 million.